pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Effects of Postural Balance Exercises in Patients With Heart Failure
Status: COMPLETED
Conditions: Heart Failure|Systolic Heart Failure|Diastolic Heart Failure
Interventions: BEHAVIORAL: Core stabilization group(CSG)|BEHAVIORAL: Wobble board group (WBG)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC
Status: COMPLETED
Conditions: HIV Infections
Interventions: DRUG: Abacavir|DRUG: Didanosine|DRUG: Abacavir+Lamivudine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Evaluating the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South Africa
Status: RECRUITING
Conditions: HIV I Infection|Tuberculosis
Interventions: BIOLOGICAL: MTBVAC|BIOLOGICAL: BCG
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Status: COMPLETED
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: Insulin glargine/Lixisenatide (HOE901/AVE0010)|DRUG: Lixisenatide (AVE0010)|DRUG: Oral anti-diabetic drugs
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Multidimensional Rehabilitation Intervention in Colorectal Cancer Survivors
Status: NOT_YET_RECRUITING
Conditions: Colorectal Cancer Survivor|Rehabilitation|Quality of Life
Interventions: BEHAVIORAL: multidimensional rehabilitation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Comparison of the Sensitive Cutaneous Block Distribution Following Femoral Nerve Block Using Two Femoral Block Techniques
Status: UNKNOWN
Conditions: Regional Anesthesia|Femoral Nerve Block
Interventions: PROCEDURE: Femoral nerve block using Ultrasound and neurostimulator|PROCEDURE: Femoral nerve block using Ultrasound|DRUG: Ropivacaine 0.5%
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Effects of Multimodal Exercises Integrated With Cognitive-behavioral Therapy in Subjects With Chronic Neck Pain
Status: SUSPENDED
Conditions: Neck Pain
Interventions: OTHER: multidisciplinary program|OTHER: General program
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy
Status: COMPLETED
Conditions: Type 2 Diabetes
Interventions: DRUG: SK-0403|DRUG: Placebo|DRUG: Sitagliptin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Medicines Reconciliation at an Intensive Care Unit
Status: UNKNOWN
Conditions: Medicines Reconciliation|Intensive Care Unit
Interventions: OTHER: Medication reconciliation at the ICU|OTHER: Medication Reconciliation at the Ward
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (CARE_PROVIDER)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis
Status: COMPLETED
Conditions: Viral Keratitis|Blindness Eye|Herpes Simplex Virus Infection|Cornea
Interventions: DRUG: BD111 Adult single group Dose
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study on the Effect of Fish Oil and Appetite
Status: COMPLETED
Conditions: Obesity|Cachexia
Interventions: DIETARY_SUPPLEMENT: Fish oil
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Effectiveness of Continuous Femoral Nerve Block Versus Single Shot Femoral Nerve Block for Pain Control
Status: TERMINATED
Conditions: Post-operative Pain
Interventions: DRUG: Bupivicaine|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Weight Management and Coping Skills Training For Patients With Knee Osteoarthritis
Status: COMPLETED
Conditions: Osteoarthritis
Interventions: BEHAVIORAL: Lifestyle Behavioral Weight Management Program|BEHAVIORAL: Pain-Coping Skills Training|OTHER: Standard Care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria
Status: COMPLETED
Conditions: Albuminuria
Interventions: DRUG: Ramipril + Irbesartan|DRUG: Ramipril + Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
Status: UNKNOWN
Conditions: Virus Diseases|Respiratory Tract Diseases|Respiratory Tract Infections|Influenza|Orthomyxoviridae Infections
Interventions: BIOLOGICAL: split-virion, non-adjuvanted H1N1 vaccine of 15 μg|OTHER: blood fix
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01)
Status: RECRUITING
Conditions: Neoplasm Metastasis
Interventions: BIOLOGICAL: Pembrolizumab|BIOLOGICAL: Favezelimab|BIOLOGICAL: Favezelimab/Pembrolizumab|BIOLOGICAL: Vibostolimab|BIOLOGICAL: Pembrolizumab/Vibostolimab
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors
Status: COMPLETED
Conditions: Advanced Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm
Interventions: DRUG: Gemcitabine Hydrochloride|OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacological Study|DRUG: Ribociclib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Caudal Block and Transversus Abdominis Plane Block in Pediatric Inguinal Hernia Repair
Status: COMPLETED
Conditions: Regional Anesthesia|Postoperative Pain, Acute
Interventions: DRUG: Bupivacaine 0.25% Injectable Solution
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy
Status: COMPLETED
Conditions: Minimal Hepatic Encephalopathy
Interventions: BIOLOGICAL: Lactobacillus GG|BIOLOGICAL: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly
Status: COMPLETED
Conditions: Influenza
Interventions: BIOLOGICAL: Pandemrix (Influenza vaccine GSK2340272A)|BIOLOGICAL: Fluarix™|BIOLOGICAL: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
Status: COMPLETED
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Pertuzumab|DRUG: Placebo|DRUG: Trastuzumab|DRUG: Docetaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis
Status: RECRUITING
Conditions: Contact Dermatitis
Interventions: OTHER: niacinamide cosmetic product|OTHER: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Using Virtual Reality (VR) Technology in Gynecological and Obstetrics Procedures
Status: NOT_YET_RECRUITING
Conditions: Virtual Reality|Anxiety|Pain
Interventions: DEVICE: VR without positive psychology|DEVICE: VR with positive psychology
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Effect of Kinesio® Taping in Chronic Ankle Instability
Status: COMPLETED
Conditions: Ankle Sprain
Interventions: PROCEDURE: taping of ankle sprain|DEVICE: Sport tex® kinesiotape|DEVICE: Pretape Cramer®
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years
Status: COMPLETED
Conditions: COVID-19
Interventions: BIOLOGICAL: Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant|BIOLOGICAL: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Status: UNKNOWN
Conditions: Peripheral T-cell Lymphoma
Interventions: DRUG: Chidamide|DRUG: prednisone|DRUG: Cyclophosphamide|DRUG: etoposide|DRUG: Methotrexate
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
Status: COMPLETED
Conditions: Arrhythmia
Interventions: DRUG: Azimilide Dihydrochloride|DRUG: placebo|DRUG: Azimilide Dihydrochloride
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of HS022 and Trastuzumab® in Combination With Vinorelbine Bitartrate Injection in the Treatment of HER2-positive Breast Cancer
Status: COMPLETED
Conditions: HER2-positive Breast Cancer
Interventions: DRUG: HS022|DRUG: Trastuzumab|DRUG: Vinorelbine Bitartrate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris
Status: WITHDRAWN
Conditions: Acne Vulgaris
Interventions: DRUG: Adapalene and Benzoyl peroxide Dalap Duo®|DRUG: Adapalene and Benzoyl peroxide Epiduo®
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions
Status: COMPLETED
Conditions: Healthcare Quality Indicators|Inappropriate Prescribing|Anticoagulant Drugs|Atrial Fibrillation|Venous Thromboembolism|Valvular Heart Disease|Brain Injury
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
Status: COMPLETED
Conditions: Solid Tumor|Anaplastic Thyroid Cancer
Interventions: DRUG: Crolibulin|DRUG: Cisplatin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Ocular-vestibular Biomarker Identification for ADHD
Status: UNKNOWN
Conditions: ADHD - Combined Type|ADHD|ADHD Predominantly Inattentive Type|ADHD, Predominantly Hyperactive - Impulsive
Interventions: DEVICE: EYE-SYNC
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease
Status: UNKNOWN
Conditions: NSCLC
Interventions: DRUG: Icotinib of routine dose|DRUG: Icotinib of high dose
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: 18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability
Status: COMPLETED
Conditions: Myocardial Infarction|Myocardial Ischemia|Atherosclerosis|Coronary Artery Disease|Coronary Stenosis|Heart Attack|Multi Vessel Coronary Artery Disease
Interventions: DIAGNOSTIC_TEST: PET-MRI|PROCEDURE: Optical Coherence Tomography
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma
Status: UNKNOWN
Conditions: Multiple Myeloma
Interventions: DRUG: depsipeptide|DRUG: bortezomib|DRUG: dexamethasone
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations
Status: RECRUITING
Conditions: Non-Small Cell Lung Cancer|Advanced Non-Small Cell Squamous Lung Cancer|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Lung Cancer|NSCLC|Advanced Lung Carcinoma|Epidermal Growth Factor Receptor C797S|Epidermal Growth Factor Receptor G719X|EGF-R Positive Non-Small Cell Lung Cancer|EGFR-TKI Resistant Mutation
Interventions: DRUG: BDTX-1535 monotherapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Status: COMPLETED
Conditions: Chronic Hepatitis C
Interventions: DRUG: BMS-650032|DRUG: BMS-790052|DRUG: BMS-791325|DRUG: Ribavirin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Mentalization-Based Therapy to Prevent Suicidal Behavior in Adolescents With Bipolar Disorder
Status: COMPLETED
Conditions: Bipolar Disorder|Suicidal Ideation
Interventions: BEHAVIORAL: Mentalization-Based Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Optimizing Closed Incision Negative Pressure Wound Therapy in Emergency Laparotomy
Status: COMPLETED
Conditions: Surgical Site Infection|Surgical Wound|Surgical Wound Infection|Surgical Complication|Surgical Wound Dehiscence|Surgical Wound Haemorrhage|Surgical Wound, Healed
Interventions: DEVICE: Incisional negative pressure wound therapy|OTHER: Control group - standard wound dressing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)
Status: TERMINATED
Conditions: Facioscapulohumeral Muscular Dystrophy|Charcot-Marie-Tooth Disease
Interventions: DRUG: ACE-083
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics
Status: COMPLETED
Conditions: Urinary Incontinence|Urgency Urinary
Interventions: DRUG: Oxybutynin, Solifenacin, Tolterodine, Trospium, or Fesoterodine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)
Status: TERMINATED
Conditions: Adult Growth Hormone Deficiency (AGHD)
Interventions: DRUG: somavaratan
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: LMN-101 in a Campylobacter Human Challenge Model
Status: COMPLETED
Conditions: Campylobacter Infections
Interventions: BIOLOGICAL: LMN-101|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.
Status: RECRUITING
Conditions: Myocarditis
Interventions: DIAGNOSTIC_TEST: Cardiac Imaging
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma
Status: COMPLETED
Conditions: Pulmonary Fibrosis|Scleroderma, Systemic
Interventions: DRUG: Bosentan
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: The Short-term Effects of Trunk Kinesio Taping on Trunk Muscle Endurance and Postural Stability in Healthy Young Adults
Status: UNKNOWN
Conditions: Kinesio Taping
Interventions: OTHER: Kinesio taping|OTHER: Sham Kinesio taping
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effects of LGI Steam Bread on Glycemia Control in T2DM in China
Status: NOT_YET_RECRUITING
Conditions: Diabete Type 2
Interventions: DIETARY_SUPPLEMENT: LGI steam bread|DIETARY_SUPPLEMENT: Diabetic diet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Cephalic Version by Acupuncture-Moxibustion for Breech Presentation
Status: COMPLETED
Conditions: Breech Presentation
Interventions: OTHER: Acupuncture moxibustion|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose:
Clinical trial: Kelulut Honey as an Alternate Source of Carbo-Loading in Abdominal Surgery Involving the Digestive System
Status: COMPLETED
Conditions: Insulin Resistance|ERAS
Interventions: DIETARY_SUPPLEMENT: Kelulut Honey|DIETARY_SUPPLEMENT: Carborie
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Maximal Plantar Pressure and Comfort Evaluation of Orthopedic Stilettos
Status: COMPLETED
Conditions: Metatarsalgia
Interventions: OTHER: orthopaedic stilettoe|OTHER: standard stiletto|OTHER: comfy trainer
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Diabetes Risk Communication Tool Evaluation
Status: COMPLETED
Conditions: Type 2 Diabetes
Interventions: BEHAVIORAL: T2D Risk Communication Tool: Relative Risk|BEHAVIORAL: T2D Risk Communication Tool: Metabolic Age|BEHAVIORAL: T2D Risk Communication Tool: Traffic Light
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: Strength, Pain and Function in Operation Iraqi Freedom/Operation Enduring Freedom Amputees: A Nurse-Managed Program
Status: COMPLETED
Conditions: Traumatic Amputation
Interventions: DEVICE: NMES (EMPI 300PV stimulator) plus standard of care|BEHAVIORAL: TMARP standard of care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND)
Status: ACTIVE_NOT_RECRUITING
Conditions: Tricuspid Regurgitation|Tricuspid Insufficiency
Interventions: DEVICE: Transcatheter Tricuspid Valve Repair
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse
Status: COMPLETED
Conditions: Diffuse Large B-Cell Lymphoma
Interventions: DRUG: Rituximab, CMC544, Gemcitabine and Oxaliplatine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Using Simplified Meal Boluses Versus Carbohydrate Counting in Adolescents With Hybrid Closed Loop Systems
Status: NOT_YET_RECRUITING
Conditions: Type 1 Diabetes
Interventions: BEHAVIORAL: Simple Meal Bolusing|BEHAVIORAL: Carbohydrate counting
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery
Status: COMPLETED
Conditions: Coronary Artery Disease|Valvular Heart Disease|Surgical Blood Loss
Interventions: DRUG: Tranexamic Acid 100 MG/ML|DRUG: normal saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Multimodal Neuroimaging Study of Brain Activation Patterns Under Ketamine
Status: COMPLETED
Conditions: Major Depressive Disorder
Interventions: DRUG: Ketamine|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives
Status: TERMINATED
Conditions: Contraception
Interventions: DRUG: ortho tricyclen|DRUG: Trinessa
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines
Status: COMPLETED
Conditions: Endometrial Adenocarcinoma
Interventions: DRUG: Ketamine|DRUG: dexmedetomidine|DRUG: bupivacaine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Characterization of Fecal Microbiota in a Population Aged 50 to 75 Years Targeted by Seasonal Vaccination
Status: COMPLETED
Conditions: Elderly Volunteers
Interventions: OTHER: Biological samples collection (blood + feces)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
Status: UNKNOWN
Conditions: Breast Cancer|Chemotherapy Induced Amenorrhea|Ovarian Function Suppression
Interventions: DRUG: Goserelin|DRUG: Toremifene
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Amblyopia and Neurovascular Coupling in the Retina of Humans
Status: WITHDRAWN
Conditions: Amblyopia|Regional Blood Flow
Interventions: PROCEDURE: Flicker|PROCEDURE: Retinal Vessel Diameter|PROCEDURE: Retinal Blood Flow
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Aripiprazole and Lexapro Drug Interaction Study
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Escitalopram on days -7 to day 14; Aripiprazole dosed starting Day 1 to day 14: 3 days at 10 mg, 4 days at 15 mg and 7 days at 20 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
Clinical trial: The MotivAir Study to Improve CPAP Adherence in OSAS Patients
Status: NOT_YET_RECRUITING
Conditions: Sleep Apnea, Obstructive|Motivational Interviewing
Interventions: BEHAVIORAL: Motivational interviewing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma
Status: RECRUITING
Conditions: B Cell Lymphoma|Aggressive Lymphoma|Diffuse Large B Cell Lymphoma|High-grade B-cell Lymphoma|Transformed Lymphoma|Follicular Lymphoma Grade 3
Interventions: DRUG: Mosunetuzumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Ankle Position and Pelvic Floor Muscle Force With Relaxation of Pelvic Floor Muscles Syndrome
Status: WITHDRAWN
Conditions: Pelvic Floor Muscle Syndrome
Interventions: OTHER: doing strengthening exercises of pelvic floor muscles
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Effect of Breast Size on the Electrical Impedance Tomography Measurement
Status: COMPLETED
Conditions: Effect of Breast Tissue on EIT Lung Monitoring
Interventions: DEVICE: Electrical impedance tomography (EIT)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
Status: COMPLETED
Conditions: Mild to Moderate Alzheimer's Disease
Interventions: DRUG: CT1812|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects
Status: COMPLETED
Conditions: Healthy Adult Subjects
Interventions: DRUG: MCI-186|DRUG: MCI-186|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Status: COMPLETED
Conditions: Ovarian Cancer|Primary Peritoneal Cavity Cancer
Interventions: BIOLOGICAL: carcinoembryonic antigen-expressing measles virus|BIOLOGICAL: oncolytic measles virus encoding thyroidal sodium iodide symporter|GENETIC: reverse transcriptase-polymerase chain reaction|OTHER: laboratory biomarker analysis
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of PNF and Static Stretching on Architecture and Viscoelastic Properties of Hemiplegic Elbow
Status: COMPLETED
Conditions: Stroke|Spasticity, Muscle
Interventions: OTHER: Exercise|OTHER: PNF Stretching|OTHER: Prolonged Stretching
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Clonidine Versus Granisetron for Shivering Prevension
Status: RECRUITING
Conditions: Post Spinal Anesthesia Shivering
Interventions: DRUG: Clonidine Injection|DRUG: Granisetron Injection|DRUG: Normal Saline 10 mL Injection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers
Status: COMPLETED
Conditions: Healthy Volunteer
Interventions: DRUG: RO4917523|DRUG: RO4917523
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
Clinical trial: What Drives Poor Care for Child Diarrhea: A Standardized Patient Experiment
Status: ACTIVE_NOT_RECRUITING
Conditions: Child Diarrhea
Interventions: BEHAVIORAL: Free distribution of ORS|BEHAVIORAL: Standardized patient with ORS preference|BEHAVIORAL: Standardized patient with Antibiotic preference|BEHAVIORAL: Standardized patient with no preference|BEHAVIORAL: Standardized patient with no preference + no financial incentive
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Using Multimedia Digital Health to Enable and Engage Pediatric Inpatients and Their Parents
Status: COMPLETED
Conditions: Inpatient Pediatric Engagement and Shared Decision-Making
Interventions: BEHAVIORAL: EMPOWER Educational Module
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Airway Scope and Macintosh Laryngoscope for Tracheal Intubation in Patients Lying on the Ground
Status: COMPLETED
Conditions: Intubation
Interventions: DEVICE: Airway Scope|DEVICE: Macintosh Laryngoscope
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients
Status: RECRUITING
Conditions: Esophageal Squamous Cell Carcinoma|Patient-reported Outcomes|Immunotherapy
Interventions: DRUG: Paclitaxel-albumin|DRUG: Cisplatin|DRUG: Carboplatin|DRUG: Tislelizumab|RADIATION: VMAT or IMRT|PROCEDURE: Esophagectomy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Demand-Driven Method for Gas Delivery in a Dental Setting
Status: UNKNOWN
Conditions: Nitrous Oxide|Dentistry|Drug Delivery System|Comfort|Feasibility|Drug Administration, Inhalation
Interventions: DEVICE: Demand-driven delivery method|DEVICE: Free-flow delivery method
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER
Clinical trial: Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)
Status: TERMINATED
Conditions: Neurofibromatosis Type 1 (NF1)
Interventions: DRUG: Cholecalciferol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency
Status: NOT_YET_RECRUITING
Conditions: Homologous Recombination Deficiency|Triple Negative Breast Cancer
Interventions: DRUG: Niraparib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Comparison of Oral Misoprostol and Vaginal Misoprostol for Cervical Ripening and Induction of Labor
Status: TERMINATED
Conditions: Labor; Forced or Induced, Affecting Fetus or Newborn|Pregnancy
Interventions: DRUG: Misoprostol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparative Efficacy of 20% Benzocaine Versus TAC Alternate Gel
Status: UNKNOWN
Conditions: Dental Pain|Postoperative Pain
Interventions: DRUG: benzocaine|DRUG: TAC alternate gel
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT
Clinical trial: Prospective Validation of Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery
Status: RECRUITING
Conditions: Venous Thromboembolism|Neurosurgery|Risk Assessment
Interventions: DIAGNOSTIC_TEST: Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib
Status: COMPLETED
Conditions: Non-squamous, Non-Small Cell Lung Cancer
Interventions: DRUG: Afatinib (Gi(l)otrif®)|DRUG: Erlotinib (Tarceva®)|DRUG: Gefitinib (IRESSA®)|DRUG: Osimertinib (Tagrisso®)|DRUG: Afatinib (Gi(l)otrif®)|DRUG: Osimertinib (Tagrisso®)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) With Different Food Choices in the Outpatient Setting
Status: COMPLETED
Conditions: Type 1 Diabetes Mellitus
Interventions: DEVICE: iAPS
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension
Status: COMPLETED
Conditions: Glaucoma|Ocular Hypertension
Interventions: DRUG: Azarga (brinzolamide 1% / timolol 0.5%)|DRUG: Cosopt (dorzolamide 2% / timolol 0.5%)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors
Status: RECRUITING
Conditions: Urothelial Cancer|Metastatic Solid Tumor
Interventions: DRUG: Colchicine
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Impact of Obstructive Sleep Apnea (OSA) Treatment on Blood Pressure Control in Chronic Kidney Disease
Status: RECRUITING
Conditions: Sleep Apnea|Chronic Kidney Diseases
Interventions: DEVICE: CPAP|DRUG: Usual care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Supracapsular Ahmed Glaucoma Valve Plate Delivery Technique for Management of Encapsulated Bleb in Pediatric Patients
Status: COMPLETED
Conditions: Glaucoma
Interventions: PROCEDURE: Supracapsular Ahmed Glaucoma Valve plate delivery technique
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis
Status: COMPLETED
Conditions: Candidemia|Mycoses|Fungal Infection|Invasive Candidiases
Interventions: DRUG: Rezafungin for Injection|DRUG: Caspofungin|DRUG: Fluconazole|DRUG: intravenous placebo|DRUG: oral placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Impact of the Central Blood Pressure Level in Cerebral Metabolic Aging: a 18F-FDG PET Study.
Status: COMPLETED
Conditions: Aging Disorder
Interventions: DEVICE: PET with a cerebral step|DEVICE: Central blood pressure measurement|OTHER: Neurocognitive tests
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis
Status: COMPLETED
Conditions: Cystic Fibrosis
Interventions: DRUG: MP-376 (Levofloxacin solution for Inhalation)|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Effects of "Telerehabılıtatıon Based Structured Home Program Implementatıons" Chıldren With Cerebral Palsy
Status: COMPLETED
Conditions: Cerebral Palsy
Interventions: OTHER: Telerehabilitation based structured home program applications
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: A Multicentre,Study of IBI133 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumours
Status: RECRUITING
Conditions: Locally Advanced Unresectable or Metastatic Solid Tumors
Interventions: BIOLOGICAL: IBI133
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)
Status: ACTIVE_NOT_RECRUITING
Conditions: Coronary Artery Disease
Interventions: DEVICE: Device: Paclitaxel-Coated PTCA Balloon Catheter|DEVICE: SeQuent Please Drug Eluting Balloon Catheter with Paclitaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma
Status: COMPLETED
Conditions: Ovarian Carcinoma
Interventions: DIETARY_SUPPLEMENT: Double-Brewed Green Tea
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
Clinical trial: Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne
Status: COMPLETED
Conditions: Acne
Interventions: DRUG: Epiduo/Tactuo|OTHER: vehicle gel|DRUG: doxycycline 200mg|DRUG: Isotretinoin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Pilot Study to Estimate the Impact of a Screening and Referral Service on Contraceptive Use
Status: COMPLETED
Conditions: Contraception Behavior
Interventions: OTHER: digital family planning screening and referral service
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy
Status: COMPLETED
Conditions: Hypogonadotrophic Hypogonadism
Interventions: DRUG: Testosterone 250mg injection|DRUG: Testosteron 50 mg transdermal gel
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology
Status: RECRUITING
Conditions: Refractory B-Cell Lymphoma|B-cell Lymphoma Recurrent
Interventions: BIOLOGICAL: CAR-T cells therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)
Status: TERMINATED
Conditions: Cholangiocarcinoma|Klatskin Tumor|Biliary Tract Cancer
Interventions: RADIATION: External beam radiation and Cyberknife radiosurgery boost and capecitabine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects
Status: COMPLETED
Conditions: Hyperkalemia
Interventions: DRUG: Sodium Zirconium Cyclosilicate|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Modulating Oscillations and Working Memory in Patients With Subdural Electrodes
Status: ENROLLING_BY_INVITATION
Conditions: Working Memory|Epilepsy
Interventions: DEVICE: Direct Cortical Stimulation|DEVICE: Direct Cortical Stimulation Sham
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Trauma-Sensitive Yoga for Female Veterans With PTSD Who Experienced Military Sexual Trauma
Status: COMPLETED
Conditions: Stress Disorders, Post-traumatic
Interventions: BEHAVIORAL: Trauma Center Trauma Sensitive Yoga Intervention (TCTSY)|BEHAVIORAL: Cognitive Processing Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma
Status: COMPLETED
Conditions: Asthma
Interventions: DRUG: GW685698X
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Gabapentin to Treat Itch in Patients With Liver Disease
Status: COMPLETED
Conditions: Liver Disease|Cholestasis|Cirrhosis|Pruritus|Itching
Interventions: DRUG: Gabapentin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
Status: COMPLETED
Conditions: Acute Liver Failure|Acute Liver Injury
Interventions: DRUG: Ornithine Phenylacetate
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough
Status: COMPLETED
Conditions: Respiratory Tract Diseases
Interventions: OTHER: Ointment containing camphor, eucalyptus oil, and menthol|OTHER: Petroleum jelly
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer
Status: COMPLETED
Conditions: Solid Tumor, Adult
Interventions: BIOLOGICAL: EOC202|DRUG: Paclitaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Growing Up Formula Versus Nutritional Supplements: Effect on Catch up Growth, Micronutrient Status, and Solid Foods Intake in Toddlers With Mild or Moderate Malnutrition
Status: RECRUITING
Conditions: Healthy Toddlers 12-36 Months of Age With Mild or Moderate Malnutrition
Interventions: DIETARY_SUPPLEMENT: Enfagrow® Neuropro Toddler Nutritional Drink|DIETARY_SUPPLEMENT: Pediasure® Grow & Gain Protein Shake for Kids
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison Between Three Freezing Protocols to Preserve Human Embryos
Status: COMPLETED
Conditions: Human Embryo Cryopreservation
Interventions: OTHER: Slow freezing|OTHER: VIT-Irvine|OTHER: Vit-Vitrolife
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Post-Operative Nausea And Vomiting Study In Female Patients
Status: COMPLETED
Conditions: Postoperative Nausea and Vomiting|Nausea and Vomiting, Postoperative
Interventions: DRUG: GW679769
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: PREVENTION
Clinical trial: Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients
Status: COMPLETED
Conditions: Acute Myelogenous Leukemia|Myelodysplastic Syndrome|Leukemia
Interventions: DRUG: 5-Azacytidine|DRUG: Ara-C|DRUG: Valproic Acid (VPA)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Structured Program of Exercise for Recipients of Kidney Transplantation
Status: RECRUITING
Conditions: Kidney Transplant; Complications|Dialysis; Complications|Physical Disability|Frailty Syndrome
Interventions: BEHAVIORAL: Structured Program of exercise for Recipients of Kidney Transplantation (WC)|BEHAVIORAL: Structured Program of exercise for Recipients of Kidney Transplantation (WC + CG)|BEHAVIORAL: Usual Care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Comparison Of Effective Radiation Shielding Between Rampart IC, M1128 Shield vs Conventional Apron And Shields In Clinical Interventional Procedures
Status: COMPLETED
Conditions: Radiation Exposure
Interventions: DEVICE: Rampart IC, M1128|DEVICE: Lead Apron and Ancillary Shield|DEVICE: Rampart IC, M1128 and Lead Apron
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER